Sulaf Assi
Dr Sulaf Assi is a senior lecturer in analytical forensic chemistry at the School of Pharmacy and Biomolecular science in Liverpool John Moores University. Her research interests spread across multidisciplinary and interdisciplinary areas related to medication safety; patient safety; counterfeit medicines, drugs and lifestyle products; spectroscopy; mixed-method research and machine learning. She has published 100+ […]
Varun Ahuja
Dr. Varun Ahuja is a veterinarian and American Board certified as well as European registered toxicologist. He accomplished his Graduation in Veterinary Sciences (BVSc & AH) and Masters degrees from G.B.Pant University, Pantnagar, Uttarakhand, India. He completed PhD in Toxicology from Department of Veterinary Medicine, Freie University, Berlin, Germany. Later on, Varun pursued post-doctoral work […]
PRESENTATION: Endotoxin Control Strategies for New Products
This presentation explores the Low Endotoxin Recovery (LER) phenomenon, the underlying chemistry and the history behind its interpretation. Attendees will learn:
Nitrites and Nitrosamines in Pharmaceuticals
Understanding their impact and ensuring compliance Nitrosamines, especially those formed through nitrites, remain a significant concern in pharmaceutical safety. Staying compliant with evolving regulations is crucial. This session will provide insights on:
Proactive Compliance:
Building Adaptive Quality Systems to Navigate Future Regulatory Landscapes This session covers:
Next-Gen Biologics Characterisation:
Pushing Boundaries
Continuous Manufacturing:
Transforming Pharmaceutical Production for Efficiency and Agility
The Smart Lab Revolution:
Digitalisation and Automation for Enhanced QA/QC Efficiency and Reliability
Innovation vs. Regulation:
Balancing the Pace of Analytical Technological Advancement with Evolving Regulatory Frameworks The pharmaceutical industry has experienced considerable transformation over the past decade, characterized by a notable shift towards biologics and a revived focus on peptide and oligonucleotide drug modalities. It has also witnessed significant changes in the regulatory landscape, particularly with the recent implementation of […]
